SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-021864
Filing Date
2018-04-02
Accepted
2018-04-02 17:23:09
Documents
1
Period of Report
2018-03-23

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 10090
  Complete submission text file 0001104659-18-021864.txt   13000
Mailing Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017 203 629-6700
Sagard Capital Partners, L.P. (Reporting) CIK: 0001423385 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 18730287

Mailing Address 280 PARK AVENUE 3RD FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE 3RD FLOOR WEST NEW YORK NY 10017 203 629-6700
Sagard Capital Partners Management Corp (Reporting) CIK: 0001423386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 18730285

Mailing Address 280 PARK AVENUE 3RD FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE 3RD FLOOR WEST NEW YORK NY 10017 203 629-6700
Sagard Capital Partners GP, Inc. (Reporting) CIK: 0001423388 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 18730286

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations